759 related articles for article (PubMed ID: 16213467)
1. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma.
Li B; Sedlacek M; Manoharan I; Boopathy R; Duysen EG; Masson P; Lockridge O
Biochem Pharmacol; 2005 Nov; 70(11):1673-84. PubMed ID: 16213467
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.
Duysen EG; Li B; Darvesh S; Lockridge O
Toxicology; 2007 Apr; 233(1-3):60-9. PubMed ID: 17194517
[TBL] [Abstract][Full Text] [Related]
3. Inherited and acquired interactions between ACHE and PON1 polymorphisms modulate plasma acetylcholinesterase and paraoxonase activities.
Bryk B; BenMoyal-Segal L; Podoly E; Livnah O; Eisenkraft A; Luria S; Cohen A; Yehezkelli Y; Hourvitz A; Soreq H
J Neurochem; 2005 Mar; 92(5):1216-27. PubMed ID: 15715671
[TBL] [Abstract][Full Text] [Related]
4. Prolonged toxic effects after cocaine challenge in butyrylcholinesterase/plasma carboxylesterase double knockout mice: a model for butyrylcholinesterase-deficient humans.
Duysen EG; Lockridge O
Drug Metab Dispos; 2011 Aug; 39(8):1321-3. PubMed ID: 21540357
[TBL] [Abstract][Full Text] [Related]
5. Butyrylcholinesterase and the control of synaptic responses in acetylcholinesterase knockout mice.
Girard E; Bernard V; Minic J; Chatonnet A; Krejci E; Molgó J
Life Sci; 2007 May; 80(24-25):2380-5. PubMed ID: 17467011
[TBL] [Abstract][Full Text] [Related]
6. Plasma B-esterase activities in European raptors.
Roy C; Grolleau G; Chamoulaud S; Rivière JL
J Wildl Dis; 2005 Jan; 41(1):184-208. PubMed ID: 15827224
[TBL] [Abstract][Full Text] [Related]
7. Effects of acetylcholinesterase and butyrylcholinesterase inhibition on breathing in mice adapted or not to reduced acetylcholinesterase.
Boudinot E; Taysse L; Daulon S; Chatonnet A; Champagnat J; Foutz AS
Pharmacol Biochem Behav; 2005 Jan; 80(1):53-61. PubMed ID: 15652380
[TBL] [Abstract][Full Text] [Related]
8. Resistance to organophosphorus agent toxicity in transgenic mice expressing the G117H mutant of human butyrylcholinesterase.
Wang Y; Boeck AT; Duysen EG; Van Keuren M; Saunders TL; Lockridge O
Toxicol Appl Pharmacol; 2004 May; 196(3):356-66. PubMed ID: 15094306
[TBL] [Abstract][Full Text] [Related]
9. Comparison of methods used for the determination of cholinesterase activity in whole blood.
Naik RS; Doctor BP; Saxena A
Chem Biol Interact; 2008 Sep; 175(1-3):298-302. PubMed ID: 18555980
[TBL] [Abstract][Full Text] [Related]
10. Screening assays for cholinesterases resistant to inhibition by organophosphorus toxicants.
Wang Y; Schopfer LM; Duysen EG; Nachon F; Masson P; Lockridge O
Anal Biochem; 2004 Jun; 329(1):131-8. PubMed ID: 15136175
[TBL] [Abstract][Full Text] [Related]
11. Albumin, a new biomarker of organophosphorus toxicant exposure, identified by mass spectrometry.
Peeples ES; Schopfer LM; Duysen EG; Spaulding R; Voelker T; Thompson CM; Lockridge O
Toxicol Sci; 2005 Feb; 83(2):303-12. PubMed ID: 15525694
[TBL] [Abstract][Full Text] [Related]
12. Identification of Carboxylesterase, Butyrylcholinesterase, Acetylcholinesterase, Paraoxonase, and Albumin Pseudoesterase in Guinea Pig Plasma through Nondenaturing Gel Electrophoresis.
Napon G; Dafferner AJ; Saxena A; Lockridge O
Comp Med; 2018 Oct; 68(5):367-374. PubMed ID: 30278860
[TBL] [Abstract][Full Text] [Related]
13. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase.
Bartling A; Worek F; Szinicz L; Thiermann H
Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809
[TBL] [Abstract][Full Text] [Related]
14. Nippostrongylus brasiliensis: infection decreases plasma butyrylcholinesterase activity in rats.
Farid AS; Horii Y
Exp Parasitol; 2009 Jun; 122(2):162-4. PubMed ID: 19245810
[TBL] [Abstract][Full Text] [Related]
15. Paraoxonase (PON1) polymorphism and activity as the determinants of sensitivity to organophosphates in human subjects.
Sirivarasai J; Kaojarern S; Yoovathaworn K; Sura T
Chem Biol Interact; 2007 Jul; 168(3):184-92. PubMed ID: 17532308
[TBL] [Abstract][Full Text] [Related]
16. The butyrylcholinesterase knockout mouse as a model for human butyrylcholinesterase deficiency.
Li B; Duysen EG; Carlson M; Lockridge O
J Pharmacol Exp Ther; 2008 Mar; 324(3):1146-54. PubMed ID: 18056867
[TBL] [Abstract][Full Text] [Related]
17. The pH dependence of dealkylation in soman-inhibited cholinesterases and their mutants: further evidence for a push-pull mechanism.
Saxena A; Viragh C; Frazier DS; Kovach IM; Maxwell DM; Lockridge O; Doctor BP
Biochemistry; 1998 Oct; 37(43):15086-96. PubMed ID: 9790671
[TBL] [Abstract][Full Text] [Related]
18. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.
Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F
Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953
[TBL] [Abstract][Full Text] [Related]
19. Asymmetric fluorogenic organophosphates for the development of active organophosphate hydrolases with reversed stereoselectivity.
Amitai G; Adani R; Yacov G; Yishay S; Teitlboim S; Tveria L; Limanovich O; Kushnir M; Meshulam H
Toxicology; 2007 Apr; 233(1-3):187-98. PubMed ID: 17129656
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment with pyridinium oximes improves antidotal therapy against tabun poisoning.
Lucić Vrdoljak A; Calić M; Radić B; Berend S; Jun D; Kuca K; Kovarik Z
Toxicology; 2006 Nov; 228(1):41-50. PubMed ID: 16982122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
